-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E7LUPrvNEnrWDQQ6f8kI4PCtXBAN5c4T1sVCmdNzs+Ivp9hbRDXfuDCh62cm/7QK 8ET0QEX6QoNVytHc/4rwvw== 0001181152-05-000003.txt : 20050611 0001181152-05-000003.hdr.sgml : 20050611 20050526100621 ACCESSION NUMBER: 0001181152-05-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050518 FILED AS OF DATE: 20050526 DATE AS OF CHANGE: 20050526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONDURANT STUART CENTRAL INDEX KEY: 0001181152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 05858395 BUSINESS ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC STREET 2: 3151 S 17TH ST CITY: WILMINGTON STATE: DE ZIP: 28412 BUSINESS PHONE: 9102510081 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-05-18 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181152 BONDURANT STUART 205 UNIVERSITY DRIVE CHAPEL HILL NC 27514 1 0 0 0 Common Stock 3580 D Stock Options (to buy) 47.58 2005-05-18 4 A 0 2729 0 A 2005-05-18 2015-05-17 Common Stock 2729 2729 D 1,580 shares are restricted stock and exempt under Rule 16(b)(3). Lisa C. Noecker attorney in fact for Stuart Bondurant 2005-05-26 -----END PRIVACY-ENHANCED MESSAGE-----